Intensity-modulated radiation therapy with concurrent carboplatin and paclitaxel for locally advanced head and neck cancer: toxicities and efficacy.

Vlacich G, Diaz R, Thorpe SW, Murphy BA, Kirby W, Sinard RJ, Shakhtour B, Shyr Y, Murphy P, Netterville JL, Yarbrough WG, Cmelak AJ
Oncologist. 2012 17 (5): 673-81

PMID: 22550060 · PMCID: PMC3360907 · DOI:10.1634/theoncologist.2011-0396

MeSH Terms (20)

Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Carboplatin Carcinoma, Squamous Cell Chemoradiotherapy Disease-Free Survival Female Head and Neck Neoplasms Humans Male Middle Aged Paclitaxel Radiotherapy, Intensity-Modulated Radiotherapy Dosage Randomized Controlled Trials as Topic Retrospective Studies Squamous Cell Carcinoma of Head and Neck Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: